Biology Reference
In-Depth Information
Ruhe, D.S., Cooper, R.D., Coatney, G.R., Josephson, E.S., 1949. Studies in human malaria.
XV. The therapeutic action of pamaquine (Plasmochin) against St. Elizabeth strain vivax
malaria. Am. J. Hyg. 49, 367-373.
Rungsihirunrat, K., Sibley, C.H., Mungthin, M., Na-Bangchang, K., 2008. Geographical dis-
tribution of amino acid mutations in
Plasmodium vivax
DHFR and DHPS from malaria
endemic areas of Thailand. Am. J. Trop. Med. Hyg. 78, 462-467.
Russel, B., Chalfein, G., Prasetyorini, B., Kenangalem, E., Piera, K., et al., 2008. Deter-
minants of in vitro drug susceptibility testing of
Plasmodium vivax
. Antimicrob. Agents
Chemother. 52, 1040-1045.
Russell, B.M., Udomsangpetch, R., Rieckmann, K.H., Kotecka, B.M., Coleman, R.E., et al.,
2003. Simple in vitro assay for determining the sensitivity of
Plasmodium vivax
isolates
from fresh human blood to antimalarials in areas where
P. vivax
is endemic. Antimicrob.
Agents Chemother. 47, 170-173.
Sa, J.M., Nomura, T., Neves, J., Baird, J.K., Wellems, T.E., et al., 2005.
Plasmodium vivax
: allele
variants of the mdr1 gene do not associate with chloroquine resistance among isolates
from Brazil, Papua, and monkey-adapted strains. Exp. Parasitol. 109, 256-259.
Sa, J.M., Yamamoto, M.M., Fernandez-Becerra, C., de Azevedo, M.F., Papakrivos, J.,
et al., 2006. Expression and function of pvcrt-o, a
Plasmodium vivax
ortholog of pfcrt,
in
Plasmodium falciparum
and
Dictyostelium discoideum
. Mol. Biochem. Parasitol.
150, 219-228.
Saleri, N., Gulletta, M., Matteelli, A., Caligaris, S., Tomasoni, L.R., et al., 2006. Acute respira-
tory distress syndrome in
Plasmodium vivax
malaria in traveler returning from Venezuela.
J. Travel. Med. 13, 112-113.
Sattabongkot, J.,Yimamnuaychoke, N., Leelaudomlipi, S., Rasameesoraj, M., Jenwithisuk, R.,
et al., 2006. Establishment of a human hepatocyte line that supports in vitro develop-
ment of the exo-erythrocytic stages of the malaria parasites
Plasmodium falciparum
and
P. vivax
. Am. J. Trop. Med. Hyg. 74, 708-715.
Schlitzer, M., 2007. Malaria chemotherapeutics part I: history of antimalarial drug devel-
opment, currently used therapeutics, and drugs in clinical development. Chem. Med.
Chem. 2, 944-986.
Schmidt, L.H., Fradkin, R., Vaughan, D., Rasco, J., 1977. Radical cure of infections with
Plasmodium cynomolgi
: a function of total 8-aminoquinoline dose. Am. J. Trop. Med. Hyg.
26, 1116-1128.
Schmidt, L.H., Fradkin, R., Genther, C., Rossan, R.N., Squires, W., 1982. Responses of
sporozoite-induced and trophozoite-induced infections to standard antimalarials. Am.
J. Trop. Med. Hyg. 31, 646-665.
Schmidt, L.H., 1978.
Plasmodium falciparum
and
Plasmodium vivax
infections in the owl mon-
key (
Aotus trivirgatus
). II. Responses to chloroquine, quinine, and pyrimethamine. Am.
J. Trop. Med. Hyg. 27, 703-717.
Schmidt, L.H., 1981. Comparative efficacies of quinine and chloroquine as companions to
primaquine in a curative drug regimen. Am. J. Trop. Med. Hyg. 30, 20-25.
Schmidt, L.H., 1983. Appraisals of compounds of diverse chemical classes for capacities
to cure infections with sporozoites of
Plasmodium cynomolgi
. Am. J. Trop. Med. Hyg.
32, 231-257.
Schmidt, L.H., 1985. Enhancement of the curative activity of primaquine by concomitant
administration of mirincamycin. Antimicrob. Agents Chemother. 27, 151-157.
Shaikh, S., Memon, H., Shaikh, A., Ahmed, I., Iohano, B., et al., 2012. Severe disease in chil-
dren hospitalized with a diagnosis of
Plasmodium vivax
in south-eastern Pakistan. Malar.
J. 11, 144.
Shannon, J.A., 1946. Chemotherapy in malaria. Bull. N. Y. Acad. Med. 22, 345-357.
Sharrock, W.W., Suwanarusk, R., Lek-Uthai, U., Edstein, M.D., Kosaisavee, V., et al., 2008.
Plasmodium vivax
trophozoites insensitive to chloroquine. Malar. J. 7, 94.
